All News

2016

September

Media Release / Sep 28, 2016

Sandoz invites young entrepreneurs to enter Sandoz HACk, a global competition to help solve healthcare access challenges

Read More
Media Release / Sep 16, 2016

Top-line results for PF-06438179 (biosimilar infliximab) demonstrate equivalent efficacy to reference product

Read More

August

Media Release / Aug 31, 2016

AirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus®[1] in persistence to treatment

Read More
Media Release / Aug 30, 2016

FDA approves Sandoz Erelzi™ to treat multiple inflammatory diseases

Read More
Media Release / Aug 18, 2016

Launch of novel on-demand news service Transplant TODAY from TTS 2016 transplant congress

Read More

July

Media Release / Jul 19, 2016

Novartis delivered solid Q2 despite full quarter of US Gleevec generic impact; significant positive innovation news strengthens future growth prospects

Read More
Media Release / Jul 13, 2016

Sandoz biosimilar etanercept recommended by FDA advisory committee for approval to treat multiple inflammatory diseases

Read More
Media Release / Jul 07, 2016

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

Read More

June

Media Release / Jun 20, 2016

Sandoz announces plans for five major global biosimilar launches by 2020

Read More
Media Release / Jun 09, 2016

New data demonstrates Sandoz' etanercept and rituximab biosimilar candidates bioequivalent to originator products

Read More

Pages